Building on evidence that Epstein–Barr virus (EBV)-specific cytotoxic T-lymphocytes exhibited superior persistence when used to generated CAR T-cells in other settings [27], Ahmed and colleagues evaluated HER2 CAR-modified virus-specific T-cells in GBM patients [28]. The gene discussed is ERBB2; the disease is glioblastoma.